Bernt Harald Helleberg

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 205 citations

Medicine, Neurology, Good Clinical Practice +10

Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

Melinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard et al. · The Lancet Neurology · 2022 · 100 citations · Full text

Medicine, Neurology, Radiology +12

Outcomes after Early Neurological Deterioration and Transitory Deterioration in Acute Ischemic Stroke Patients

Bernt Harald Helleberg, Bent Indredavik · Cerebrovascular Diseases · 2016 · 50 citations

Nursing, Neurology, Condition Assessment +16

Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study

Bernt Harald Helleberg, Hanne Ellekjær, Gitta Rohweder et al. · BMC Neurology · 2014 · 25 citations · Full text

Medicine, Neurology, Neurosurgery +17